menu

Spotlight On Fetal Fibronectin: The Benefits of a High Negative Predictive Value in Management of Preterm Labor

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Spotlight On Fetal Fibronectin: The Benefits of a High Negative Predictive Value in Management of Preterm Labor

Learn more about the benefits of a high negative predictive value in the management of preterm labor
  • Sponsored by

  • Overview

    Of women who present with preterm contractions, only 10% of deliveries are preterm highlighting the imprecise nature of correlating symptoms with true preterm labor (PTL). This dilemma results in unnecessary hospitalizations and interventions, contributing to a drain on resources within the health care system and possibly overexposing patients to treatments such as antenatal corticosteroids and tocolytics.

    In this episode, the spotlight is on The Benefits of a High Negative Predictive Value in Management of Preterm Labor. This supplement preview will address the dilemma healthcare professionals face regarding the imprecise nature of correlating symptoms of true preterm labor and the dilemma of unnecessary hospitalization and interventions that contribute to a burden on resources within the healthcare system. Originally published in Contemporary Ob/Gyn, the article is authored by Brigid McCue and Vanessa E. Torbenson.

    Link to supplement on Contemporary Ob/Gyn website:

    http://contemporaryobgyn.modernmedicine.com/contemporary-obgyn/news/fetal-fibronectin-benefits-high-negative-predictive-value-management-preterm-labor

     

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.